Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 22

Showing 22 citing articles:

The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
Theodoros Pettas, Sofia Lachanoudi, Filippos F. Karageorgos, et al.
World Journal of Transplantation (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 1
Harnessing the evolving CRISPR/Cas9 for precision oncology
Tianye Li, Shuiquan Li, Yue Kang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas
Francesco D’Alò, Silvia Bellesi, Elena Maiolo, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2243-2243
Open Access | Times Cited: 4
GBM immunotherapy: Exploring molecular and clinical frontiers
Mrinal K. Ghosh, Sunny Kumar, Sabana Begam, et al.
Life Sciences (2024) Vol. 356, pp. 123018-123018
Closed Access | Times Cited: 4
Current advancements in cellular immunotherapy for autoimmune disease
Corbett T. Berry, C. Pritchett Frazee, Patrick J. Herman, et al.
Seminars in Immunopathology (2025) Vol. 47, Iss. 1
Open Access
A Review of CAR T Cells and Adoptive T-Cell Therapies in Lymphoid and Solid Organ Malignancies
Dinah V. Parums
Medical Science Monitor (2025) Vol. 31
Closed Access
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects
Zahid Rafiq, M.J. Kang, Hampartsoum B. Barsoumian, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Tumor Microenvironment Dynamics of Triple-Negative Breast Cancer Under Radiation Therapy
Suryakant Niture, Subhajit Ghosh, Jerry J. Jaboin, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2795-2795
Open Access
New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK
Saade Abdalkareem Jasim, Harikumar Pallathadka, G. V. Sivaprasad, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access
Engineering innate immune cells for cancer immunotherapy
Mubin Tarannum, Xizhong Ding, Marta Barisa, et al.
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 516-533
Closed Access
CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
Wangshu Li, Xiuying Wang, Xu Zhang, et al.
(2024)
Open Access | Times Cited: 3
Highlight of 2023: From fundamental studies to clinical trials, the importance of NK cells against cancer
Capucine Bourel, Sylvie Lesage
Immunology and Cell Biology (2024) Vol. 102, Iss. 6, pp. 441-443
Open Access | Times Cited: 2
The investigation of oncolytic viruses in the field of cancer therapy
Zijun Yuan, Yinping Zhang, Xiang Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Cancer Metastases: Tailoring the Targets
Manasi S. Pote, Deepshikha Singh, Aparna M. A, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35369-e35369
Open Access | Times Cited: 2
CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
Wangshu Li, Xiuying Wang, Xu Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1035-1035
Open Access | Times Cited: 2
The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives
Sana Ahuja, Sufian Zaheer
Korean Journal of Clinical Oncology (2024) Vol. 20, Iss. 2, pp. 51-73
Closed Access | Times Cited: 2
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives
Alain Lescoat, Monalisa Ghosh, Stephan Kadauke, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access | Times Cited: 1
The future of cellular therapy for the treatment of renal cell carcinoma
Nada Chaoul, E Lauricella, Andrea Giglio, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 11, pp. 1245-1259
Closed Access | Times Cited: 1
In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy
Weiyue Zhang, Xin Huang
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy
Zhengzhou Qiu, Li Zhao, Xingfei Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
Wangshu Li, Jiuxiang Feng, Jianan Peng, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Page 1

Scroll to top